[go: up one dir, main page]

AU2003276009A8 - Regulation of human 3', 5' cyclic nucleotide phosphodiesterase pde1c - Google Patents

Regulation of human 3', 5' cyclic nucleotide phosphodiesterase pde1c

Info

Publication number
AU2003276009A8
AU2003276009A8 AU2003276009A AU2003276009A AU2003276009A8 AU 2003276009 A8 AU2003276009 A8 AU 2003276009A8 AU 2003276009 A AU2003276009 A AU 2003276009A AU 2003276009 A AU2003276009 A AU 2003276009A AU 2003276009 A8 AU2003276009 A8 AU 2003276009A8
Authority
AU
Australia
Prior art keywords
pde1c
regulation
human
cyclic nucleotide
nucleotide phosphodiesterase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003276009A
Other versions
AU2003276009A1 (en
Inventor
Jiing-Ren Liou
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer Healthcare AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare AG filed Critical Bayer Healthcare AG
Publication of AU2003276009A1 publication Critical patent/AU2003276009A1/en
Publication of AU2003276009A8 publication Critical patent/AU2003276009A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003276009A 2002-10-01 2003-09-30 Regulation of human 3', 5' cyclic nucleotide phosphodiesterase pde1c Abandoned AU2003276009A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US41463402P 2002-10-01 2002-10-01
US60/414,634 2002-10-01
US43444402P 2002-12-19 2002-12-19
US60/434,444 2002-12-19
PCT/EP2003/010833 WO2004031375A2 (en) 2002-10-01 2003-09-30 Regulation of human 3’, 5’ cyclic nucleotide phosphodiesterase pde1c

Publications (2)

Publication Number Publication Date
AU2003276009A1 AU2003276009A1 (en) 2004-04-23
AU2003276009A8 true AU2003276009A8 (en) 2004-04-23

Family

ID=32073336

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003276009A Abandoned AU2003276009A1 (en) 2002-10-01 2003-09-30 Regulation of human 3', 5' cyclic nucleotide phosphodiesterase pde1c

Country Status (2)

Country Link
AU (1) AU2003276009A1 (en)
WO (1) WO2004031375A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1606626A2 (en) * 2003-03-13 2005-12-21 Bayer HealthCare AG Diagnostics and therapeutics for diseases associated with phosphodi-esterase 1c (pde1c)
US20090030065A1 (en) * 2005-06-17 2009-01-29 Nycomed Gmbh Use of Pde1c and Inhibitors Thereof
WO2010065617A1 (en) * 2008-12-02 2010-06-10 University Of Utah Research Foundation Pde1 as a target therapeutic in heart disease
EP2968338B1 (en) * 2013-03-15 2019-01-09 Intra-Cellular Therapies, Inc. Pde1 inhibitors for use in the treatment and/or prevention of cns injuries, and pns diseases, disorders or injuries
US10682354B2 (en) 2016-03-28 2020-06-16 Intra-Cellular Therapies, Inc. Compositions and methods
EP3970719A1 (en) 2016-09-12 2022-03-23 Intra-Cellular Therapies, Inc. Pde1 inhibitor for use in a method of treatment or prophylaxis of inflammation and/or an inflammatory disease or disorder
US12364695B2 (en) 2020-06-02 2025-07-22 Intra-Cellular Therapies, Inc. Methods of treating inflammatory disease

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE250629T1 (en) * 1991-04-19 2003-10-15 Univ Washington DNA CODING FOR MAMMAL PHOSPHODIESTERASES
EP1308459A3 (en) * 2001-11-05 2003-07-09 Research Association for Biotechnology Full-length cDNA sequences

Also Published As

Publication number Publication date
WO2004031375A2 (en) 2004-04-15
AU2003276009A1 (en) 2004-04-23
WO2004031375A3 (en) 2004-07-15

Similar Documents

Publication Publication Date Title
IL159105A0 (en) Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses thereof
IL173299A0 (en) Methods of treating or preventing autoimmune diseases with 2,4- pyrimidinediamine compounds
IL161865A (en) System for the stimulation of hair growth
AU2003261409A8 (en) Temperature regulated clothing
EP1545558A4 (en) 1, 3, 5-triazines for treatment of viral diseases
IL163947A0 (en) Methods/devices for regulating patient's temperature
MXPA03006403A (en) Synthesis of temozolomide and analogs.
MXPA03006402A (en) Synthesis of temozolomide and analogs.
IL164887A0 (en) Therapeutic 1,2,3,6-tetrahydropyrimidine-2-one compositions and methods therewith
AU2003276009A8 (en) Regulation of human 3', 5' cyclic nucleotide phosphodiesterase pde1c
IL159638A0 (en) Hair lotion stimulating hair growth
EP1379131A4 (en) Regulation of weight
GB2398493B (en) Hairdresser's masking aid
AU2003293582A8 (en) Stimulation of hair regrowth
AU2003269257A8 (en) Regulation of cap-1
AU2003250329A8 (en) Regulation of novel human asparagine-hydroxylases
AU2003240688A1 (en) Regulation of human kinase
AU2002352253A8 (en) Regulation of human sialyltransferase
AU2002231741A1 (en) Regulation of human tau-tubulin kinase
SI1534286T1 (en) Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
GB0217447D0 (en) Personal deodorant
AU2003287959A8 (en) Regulation of human pde6b
EP1536008A4 (en) 2',5' -oligoadenylate phosphodiesterase
AU2003206781A1 (en) Regulation of human thymidylate kinase
GB0222015D0 (en) Means of assembly-bozz 2

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase